OncLive - Clinical Oncology News, Cancer Expert Insights
OncLive - Clinical Oncology News, Cancer Expert Insights
Spotlight
The OncLive Insider app is live!CME Opportunities
Specialty
View MoreBreast CancerLung CancerGastrointestinal CancerGenitourinary CancersOvarian CancerProstate CancerMelanoma & Skin CancerMCLMPNCAR T-cell TherapyChronic Lymphocytic LeukemiaGynecologic OncologyHematologic OncologyImmuno-OncologyMultiple MyelomaUrothelial Cancer
News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
PartnersPublications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker ConsortiumSubscribe
  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information

© 2025 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Spotlight
  • The OncLive Insider app is live!
  • CME Opportunities
SpecialtySee All >
  • Breast Cancer
  • Lung Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Ovarian Cancer
  • Prostate Cancer
  • Melanoma & Skin Cancer
  • MCL
  • MPN
  • CAR T-cell Therapy
  • Chronic Lymphocytic Leukemia
  • Gynecologic Oncology
  • Hematologic Oncology
  • Immuno-Oncology
  • Multiple Myeloma
  • Urothelial Cancer
OncLive SOSS
  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
  • MJHLS Brand Logo

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Multiple Myeloma: Emerging Concepts in Management

EP. 1: Risk Assessment for Myeloma

January 23rd 2018

EP. 2: Managing High-Risk Smoldering Myeloma

January 23rd 2018

EP. 3: Upfront Therapy Approaches in Myeloma

January 23rd 2018

EP. 4: Upfront Combination Therapies in Myeloma

January 23rd 2018

EP. 5: Impact of Maintenance Therapy in Myeloma

January 23rd 2018

EP. 6: The Role of Transplant in Myeloma

January 23rd 2018

EP. 7: Daratumumab-Based Regimens in R/R Myeloma

January 23rd 2018

EP. 8: Impact of Elotuzumab in R/R Myeloma Therapies

January 23rd 2018

EP. 9: Adding Carfilzomib to R/R Myeloma Regimens

January 23rd 2018

EP. 10: The Role of MRD Testing in Myeloma

January 23rd 2018

EP. 11: Impact of MRD Assessment on Myeloma Treatment

January 23rd 2018

EP. 12: Other Agents for Treating Myeloma

January 23rd 2018

EP. 13: Immunotherapies in Myeloma

January 23rd 2018

EP. 14: Improving Outcomes in Myeloma

January 23rd 2018

EP. 15: Looking to the Future of Myeloma Care

January 23rd 2018